期刊文献+

大肠癌患者血清CEA和CA199表达与临床病理因素相关性的回顾性分析 被引量:13

Clinical characteristic of left and right colorectal cancer and its correlation with expression of CEA and CA199
原文传递
导出
摘要 目的:分析Ⅱ期大肠癌(CRC)肿瘤部位与肿瘤标志CEA和CA199表达差异,探讨大肠癌临床病理及分子生物学因素与预后的相关性。方法:对近10年中山大学附属肿瘤医院217例临床Ⅱ期左右侧CRC术后患者进行回顾性分析。结果:左大肠癌89例(41.0%),右大肠癌128例(59.0%)。经χ2检验,左右侧大肠癌肿瘤标志CEA水平差异有统计学意义,P=0.029;年龄差异也有统计学意义,P=0.005。生存亚组分析结果显示,右侧大肠癌CA199阳性患者生存率低于阴性,P=0.160,而左侧则无统计学意义,P=0.256。独立预后因素为肿瘤部位、肿瘤大体和术后复发转移(HR分别为1.97、0.47和6.74)。结论:CEA、肿瘤部位、肿瘤大体和术后复发转移是独立预后因素;右侧大肠癌患者血清CA199阳性与预后差相关。 OBJECTIVE: To analyze the tumor marker CEA,CA199 expression in stage Ⅱ colorectal cancer(CRC) and to discuss the correlationship between the prognosis of CRC and its clinical pathology and molecular biological factors. METHODS: The clinical data of 217 patients during the past ten years in the affiliated oncology hospital of Sun Yat-sen University were analyzed retrospectively. RESULTS: The left colorectal cancer were 89 cases (41.0 %) and the right were 128 cases (59.0%). Between the left and right cases CEA and age had significantly differences (P=0. 029; P=0. 005). Subgroup Kaplan-Meier analyze of CA199 in the right location shown that the patients with a high level had a shorter OS than those with low. The independent prognostic factors were tumor location, tumor morphology, recurrence and metas- tasis (HR respectively were 1.97, 0.47 and 6.74). CONCLUSIONS: CEA is a prognostic factor on location, volume and relapse and metastsis between left and right colorectal cancer. In the right location the patients with a high level of CA199 have a shorter OS. Tumor site is an independent prognostic factor and it can be used as a reference of clinical medicine and treatment.
出处 《中华肿瘤防治杂志》 CAS 北大核心 2012年第15期1169-1172,共4页 Chinese Journal of Cancer Prevention and Treatment
关键词 结直肠肿瘤/血液 回顾性研究 预后 CEA CA199 colorectal neoplasms/blood retrospective studies prognosis CEA CA199
  • 相关文献

参考文献16

二级参考文献129

  • 1莫善兢.大肠癌流行病学与普查研究进展[J].实用肿瘤杂志,1993,8(3):181-183. 被引量:7
  • 2孟凡和,聂军,蔡学全,白衍.广东人大肠癌危险因素的调查[J].第一军医大学学报,1994,14(4):281-283. 被引量:6
  • 3王代科,夏锋.大肠癌术后的复发和转移[J].中国实用外科杂志,1995,15(12):714-716. 被引量:29
  • 4Carpelan Holmstrom M, Louhimo J,Stenman U H, et al. Estimating the probability of cancer with several tumor markers in palients with colorectal disease[J]. Oncology,2004,66(4) :296-302.
  • 5Carpelan- Holmst rom M, Louhimo J, Stenman U H, et al. CEA,CA242, CA19-9, CA72 4 and hCGbeta in the diagnosis of recurrent colorectal cancer[J]. Tumour Biol,2004,25(5 6) :228-234.
  • 6LaiI R,Lee W J,Huang M T,et al. Comparison of serum CA724, CEA,TPA,CA199 andCA125 level singastric cancer palient sand correlation with recurrence [ J ], Hepato gastroenterology, 2002, 49(46):1157-1160.
  • 7尹伯元.放射免疫分析在医学中的应用[M].北京:原子能出版社,2001.316-318.
  • 8Asbun HJ,Hughes KS.Management of recurrent and metastatic colorectal carcinoma[J].Surg Clin North Am,1993,73(1):145.
  • 9张太平,赵玉沛.胰腺癌的肿瘤标志物[J].中国实验诊断学,1997,1(3):11-13. 被引量:9
  • 10Jemal A,Thomas A,Murray T,Thun M.Cancer statistics,2002.CA Cancer J Clin2002;52:23-47.

共引文献152

同被引文献150

引证文献13

二级引证文献106

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部